Advancing Vision Summit Program

#1 lens brand recommended by eye care professionals worldwide*

FDA Market Authorized

*Based on an average recommendation with quantitative research conducted in 8 countries (Brazil, Canada, China, France, India, Italy, UK, and the US) among a representative sample of 1560 Eye Care Professionals: 1047 opticians, 513 optometrists between January and June 2022. These 8 countries represent: 63% of total world in lens volume. †Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6–12 years at initiation of treatment. Essilor® Stellest® lenses slowed myopia progression by 71% on average over 2 years† 1 .

1. Essilor International, data on file (2025). © Essilor International – October 2025. Essilor®, Evolving Vision™ and Stellest® are trademarks of Essilor International. Essilor® Stellest® lenses slowed myopia progression by 71% on average over 2 years † 1 *Based on an average recommendation with quantitative research conducted in 8 countries (Brazil, Canada, China, France, India, Italy, UK, and the US) among a representative sample of 1560 Eye Care Professionals: 1047 opticians, 513 optometrists between January and June 2022. These 8 countries represent: 63% of total world in lens volume. †Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6–12 years at initiation of treatment. 1. Essilor International, data on file (2025). ©2026 Essilor of America, Inc. All rights reserved. Essilor® Stellest® is a registered trademark of Essilor International. 09/26 HB

evolving vision

14

ADVANCING VISION SUMMIT